These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism. Liu L; Banks SM; Barnes KM; Sherins RJ J Clin Endocrinol Metab; 1988 Dec; 67(6):1140-5. PubMed ID: 3142911 [TBL] [Abstract][Full Text] [Related]
25. [Drug treatment of cryptorchidism]. Zucchini S; Cacciari E Pediatr Med Chir; 1994; 16(6):519-20. PubMed ID: 7708531 [TBL] [Abstract][Full Text] [Related]
26. [Treatment of cryptorchism with LHRH nasal spray]. Borkenstein M; Zobel V Wien Klin Wochenschr; 1985 Apr; 97(9):414-6. PubMed ID: 2860754 [TBL] [Abstract][Full Text] [Related]
27. [Treatment of undescended testis with gonadorelin (LH-RH) via intranasal spray]. de Muinck Keizer-Schrama SM; Hazebroek FW; Drop SL; Molenaar JC; Visser HK Ned Tijdschr Geneeskd; 1988 Apr; 132(17):768-72. PubMed ID: 2897635 [No Abstract] [Full Text] [Related]
28. [LHRH and cryptorchism. The results in a selected group of patients]. Agliardi AC; Borzani M; Olivani P Pediatr Med Chir; 1990; 12(4):371-3. PubMed ID: 1981611 [TBL] [Abstract][Full Text] [Related]
29. [Intranasal gonadorelin in the treatment of cryptorchism]. Beretta G; Zanollo A Arch Ital Urol Nefrol Androl; 1989 Sep; 61(3):333-5. PubMed ID: 2572057 [TBL] [Abstract][Full Text] [Related]
32. Effect of gonadotropins in the induction of spermatogenesis in human prepubertal testis. Bergadá C; Mancini RE J Clin Endocrinol Metab; 1973 Dec; 37(6):935-43. PubMed ID: 4148140 [No Abstract] [Full Text] [Related]
33. [Cryptorchism and treatment of cryptorchism. Medical approach to the problem]. Cacciari E Minerva Pediatr; 1976 Jul; 28(23):1473-4. PubMed ID: 13280 [No Abstract] [Full Text] [Related]
34. [Results of intranasal administration of synthetic luteinizing hormone-releasing hormone for nondescended testes]. Wit JM; Delemarre-van de Waal HA; Jansen M; Burger-de Geus A; Bax NM; Vos A; Rövekamp MH; Ekkelkamp S; van den Brande JL Ned Tijdschr Geneeskd; 1985 Feb; 129(7):300-4. PubMed ID: 2858061 [No Abstract] [Full Text] [Related]
35. [Treatment of cryptorchism with human chorionic gonadotropin. Problem of dosage]. Rath F Wien Med Wochenschr; 1971 Oct; 121(42):740-1. PubMed ID: 4398929 [No Abstract] [Full Text] [Related]
37. [Therapy of cryptorchism with special reference to hormone therapy using gonabion]. Waschulewski H Zentralbl Chir; 1972 Apr; 97(17):521-8. PubMed ID: 4403063 [No Abstract] [Full Text] [Related]
38. [Can orchidopexy as treatment of undescended testes be replaced by gonadorelin (LH-RH) via nasal spray?]. Hazebroek FW; de Muinck Keizer-Schrama SM; Visser HK; Molenaar JC Ned Tijdschr Geneeskd; 1988 Apr; 132(17):773-6. PubMed ID: 2897636 [No Abstract] [Full Text] [Related]
39. Clinical effect of cryptocur by undescended testicles. Papp G; Hoznek A Andrologia; 1989; 21(4):391-5. PubMed ID: 2571314 [TBL] [Abstract][Full Text] [Related]
40. [Results of the combination treatment of cryptorchidism with human chorionic gonadotropin and human menopausal gonadotropin]. Prados R; Chamorro MI; de la Morena ML; Rodríguez MD; Lazareno NL; Rodríguez-Arnao MD; Lorenzo L Rev Clin Esp; 1988 May; 182(8):419-22. PubMed ID: 2902659 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]